BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 37879874)

  • 41. [Clinical analysis of level II occult metastasis of papillary thyroid carcinoma].
    Zhang LY; Zhou X; Yao XF; Zhang Q; Zhang L
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2011 Sep; 46(9):733-7. PubMed ID: 22177040
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Should subcentimeter non-invasive encapsulated, follicular variant of papillary thyroid carcinoma be included in the noninvasive follicular thyroid neoplasm with papillary-like nuclear features category?
    Xu B; Farhat N; Barletta JA; Hung YP; Biase D; Casadei GP; Onenerk AM; Tuttle RM; Roman BR; Katabi N; Nosé V; Sadow P; Tallini G; Faquin WC; Ghossein R
    Endocrine; 2018 Jan; 59(1):143-150. PubMed ID: 29204912
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Cervical lymph node metastasis in clinical N0 papillary thyroid carcinoma].
    Yan DG; Zhang B; An CM; Zhang ZM; Li ZJ; Xu ZG; Tang PZ
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2011 Nov; 46(11):887-91. PubMed ID: 22335972
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The role of two tumor foci for predicting central lymph node metastasis in papillary thyroid carcinoma: A meta-analysis.
    Feng J; Gan X; Shen F; Cai W; Xu B
    Int J Surg; 2018 Apr; 52():166-170. PubMed ID: 29481991
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Related factors analysis for lymph node metastasis in papillary thyroid carcinoma: a series of 2 073 patients].
    Sun QH; Zhang L; Yang JB; Liu YW; Liang F; Shi H; Liu ZW; Chen G; Chen SG; Shang ZH; Hu SB; Dong YW; Li YL; Li XY
    Zhonghua Wai Ke Za Zhi; 2017 Aug; 55(8):592-598. PubMed ID: 28789509
    [No Abstract]   [Full Text] [Related]  

  • 46. Clinical and pathologic predictors of central lymph node metastasis in papillary thyroid microcarcinoma: a retrospective cohort study.
    Gui CY; Qiu SL; Peng ZH; Wang M
    J Endocrinol Invest; 2018 Apr; 41(4):403-409. PubMed ID: 28884301
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Risk Factors of Cervical Lymph Node Metastasis in Papillary Thyroid Microcarcinoma:An Analysis Based on Data from the Surveillance, Epidemiology and End Results Database].
    Zheng KS; Zeng Y; Chen C; Wu YZ; Chen B; Ying WB; Zheng KW
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2018 Dec; 40(6):736-743. PubMed ID: 30606382
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Clinical analysis of mediastinal lymph node dissection through sternotomy approach in the treatment of papillary thyroid carcinoma with mediastinal lymph node metastasis].
    Shao K; Gao SG; Xue Q; Gao YS; Li J; Wang YG; Li ZS; Lei WD; Wang B; Feng FY; Lyu F; Chen XJ; Xu ZG; Liu WS; Liu SY; Wang XL; Li ZJ; Liu J; He J
    Zhonghua Yi Xue Za Zhi; 2020 Jun; 100(24):1866-1871. PubMed ID: 32575929
    [No Abstract]   [Full Text] [Related]  

  • 49. Papillary thyroid microcarcinomas that metastasize to lymph nodes.
    Dirikoc A; Tam AA; Ince N; Ozdemir D; Topaloglu O; Alkan A; Yazgan AK; Ersoy R; Cakir B
    Am J Otolaryngol; 2021; 42(5):103023. PubMed ID: 33838358
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Risk factors of metastasis to the lymph nodes posterior to the right recurrent laryngeal nerve in papillary thyroid carcinoma.
    Hou J; Shan H; Zhang Y; Fan Y; Wu B
    Eur Arch Otorhinolaryngol; 2020 Mar; 277(3):881-886. PubMed ID: 31792653
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Clinical predictors of lymph node metastasis and survival rate in papillary thyroid microcarcinoma: analysis of 3607 patients at a single institution.
    Xu Y; Xu L; Wang J
    J Surg Res; 2018 Jan; 221():128-134. PubMed ID: 29229118
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Which is preferred for initial treatment of papillary thyroid cancer, total thyroidectomy or lobotomy?
    Wu Z; Han L; Li W; Wang W; Chen L; Yao Y; Wang Y
    Cancer Med; 2021 Mar; 10(5):1614-1622. PubMed ID: 33512778
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Clinicopathological characteristics of papillary thyroid microcarcinoma and risk factors for central lymph node metastasis].
    Wu YL; Sun JM; Zhang JJ; Cui QX; Zheng WH; Li XR
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2017 Jun; 52(6):426-429. PubMed ID: 28635214
    [No Abstract]   [Full Text] [Related]  

  • 54. Should familial disease be considered as a negative prognostic factor in micropapillary thyroid carcinoma?
    Capezzone M; Secchi C; Fralassi N; Cantara S; Brilli L; Ciuoli C; Pilli T; Maino F; Forleo R; Pacini F; Castagna MG
    J Endocrinol Invest; 2019 Oct; 42(10):1205-1213. PubMed ID: 30927240
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Rethinking Low-Risk Papillary Thyroid Cancers < 1cm (Papillary Microcarcinomas): An Evidence Review for Recalibrating Diagnostic Thresholds and/or Alternative Labels.
    Ma T; Semsarian CR; Barratt A; Parker L; Kumarasinghe MP; Bell KJL; Nickel B
    Thyroid; 2021 Nov; 31(11):1626-1638. PubMed ID: 34470465
    [No Abstract]   [Full Text] [Related]  

  • 56. Tumor border pattern and size help predict lymph node status in papillary microcarcinoma: A clinicopathologic study.
    Taşkın OÇ; Armutlu A; Ağcaoğlu O; Peker Ö; Terzioğlu T; Demirkol MO; Tezelman S; Kapran Y
    Ann Diagn Pathol; 2020 Oct; 48():151592. PubMed ID: 32871504
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The Clinical Significance of the Right Para-Oesophageal Lymph Nodes in Papillary Thyroid Cancer.
    Chang H; Yoo RN; Kim SM; Kim BW; Lee YS; Lee SC; Chang HS; Park CS
    Yonsei Med J; 2015 Nov; 56(6):1632-7. PubMed ID: 26446647
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Risks of central lymph node metastasis in papillary thyroid carcinoma with or without multifocality in at least one lobe: A multi-center analysis.
    Heng Y; Yang Z; Lin J; Liu Q; Cai W; Tao L
    Oral Oncol; 2022 Nov; 134():106185. PubMed ID: 36191477
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Identifying the clonal relationship model of multifocal papillary thyroid carcinoma by whole genome sequencing.
    Xia M; Li H; Ma Q; Yu D; Li J; Zhang Y; Sheng Y; Guo Y
    Cancer Lett; 2017 Jun; 396():110-116. PubMed ID: 28315434
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Evaluation of central lymph node dissection for papillary thyroid carcinoma in cN0 T1/T2].
    Zhao SY; Ma YH; Yin Z; Zhan XX; Cheng RC; Qian J
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2018 Feb; 53(2):105-109. PubMed ID: 29429179
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.